These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Robust meta-analytic-predictive priors in clinical trials with historical control information. Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546 [TBL] [Abstract][Full Text] [Related]
3. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes. Moatti M; Chevret S; Zohar S; Rosenberger WF Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511 [TBL] [Abstract][Full Text] [Related]
4. Performance of informative priors skeptical of large treatment effects in clinical trials: A simulation study. Pedroza C; Han W; Truong VTT; Green C; Tyson JE Stat Methods Med Res; 2018 Jan; 27(1):79-96. PubMed ID: 26668090 [TBL] [Abstract][Full Text] [Related]
5. A natural lead-in approach to response-adaptive allocation for continuous outcomes. Donahue E; Sabo RT Pharm Stat; 2021 May; 20(3):563-572. PubMed ID: 33484036 [TBL] [Abstract][Full Text] [Related]
6. On the choice of parameterisation and priors for the Bayesian analyses of Mendelian randomisation studies. Jones EM; Thompson JR; Didelez V; Sheehan NA Stat Med; 2012 Jun; 31(14):1483-501. PubMed ID: 22415699 [TBL] [Abstract][Full Text] [Related]
8. Comparison of single-arm vs. randomized phase II clinical trials: a Bayesian approach. Sambucini V J Biopharm Stat; 2015; 25(3):474-89. PubMed ID: 24896838 [TBL] [Abstract][Full Text] [Related]
9. The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies. Barry WT; Perou CM; Marcom PK; Carey LA; Ibrahim JG J Biopharm Stat; 2015; 25(1):66-88. PubMed ID: 24836519 [TBL] [Abstract][Full Text] [Related]
10. Continuous Bayesian adaptive randomization based on event times with covariates. Cheung YK; Inoue LY; Wathen JK; Thall PF Stat Med; 2006 Jan; 25(1):55-70. PubMed ID: 16025549 [TBL] [Abstract][Full Text] [Related]
11. Power and sample size simulations for Randomized Play-the-Winner rules. Guimaraes P; Palesch Y Contemp Clin Trials; 2007 Jul; 28(4):487-99. PubMed ID: 17321219 [TBL] [Abstract][Full Text] [Related]
12. Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: a tutorial. Zohar S; Teramukai S; Zhou Y Contemp Clin Trials; 2008 Jul; 29(4):608-16. PubMed ID: 18201945 [TBL] [Abstract][Full Text] [Related]
13. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials. Brutti P; De Santis F; Gubbiotti S Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415 [TBL] [Abstract][Full Text] [Related]
14. A covariate adjusted two-stage allocation design for binary responses in randomized clinical trials. Bandyopadhyay U; Biswas A; Bhattacharya R Stat Med; 2007 Oct; 26(24):4386-99. PubMed ID: 17348082 [TBL] [Abstract][Full Text] [Related]
15. Bayesian sample size calculations in phase II clinical trials using informative conjugate priors. Mayo MS; Gajewski BJ Control Clin Trials; 2004 Apr; 25(2):157-67. PubMed ID: 15020034 [TBL] [Abstract][Full Text] [Related]
16. A Method for Constructing Informative Priors for Bayesian Modeling of Occupational Hygiene Data. Quick H; Huynh T; Ramachandran G Ann Work Expo Health; 2017 Jan; 61(1):67-75. PubMed ID: 28395307 [TBL] [Abstract][Full Text] [Related]
17. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes. Proper J; Connett J; Murray T Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267 [TBL] [Abstract][Full Text] [Related]
18. Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes. Stamey JD; Natanegara F; Seaman JW J Biopharm Stat; 2013; 23(4):790-803. PubMed ID: 23786161 [TBL] [Abstract][Full Text] [Related]
19. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups. Kikuchi T; Gittins J Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784 [TBL] [Abstract][Full Text] [Related]
20. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test. Yu Q; Zhu L; Zhu H Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]